In conclusion, non-malignant tissues from women ≤ 50 years of age showed markedly lower ERα and AR alongside stronger ERβ and PGR proteins than men and women aged ≥ 60 years, which could explain the commonly reported lower CRC incidence in premenopausal women. The gene discussed is ESR2; the disease is colorectal carcinoma.